Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1425 (LINC01425)

Target
LINC01425
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1425 (LINC01425) is a long intergenic non-coding RNA gene that produces a transcript not encoding a protein but potentially playing regulatory roles at the RNA level[1][3][5]. Like other lincRNAs, it is classified as a long non-coding RNA greater than 200 nucleotides, found in regions of the genome not overlapping protein-coding genes[3][5]. LINC01425 and related lincRNAs are implicated in the *fine-tuning of gene expression*, often in a tissue-specific manner, through mechanisms like chromatin remodeling, transcriptional regulation, RNA stabilization, and potentially through enhancer-like activities[3][5]. LINC01425 has been identified in bioinformatic analyses as part of lncRNA signatures that distinguish tumor from normal tissue, especially in lung cancer datasets, supporting a potential role as a cancer biomarker and diagnostic/prognostic tool, though not as a direct therapeutic target or enzyme[2]. No known drugs are reported to target LINC01425 directly, and its molecular mechanism, interacting proteins, and functional effects likely involve regulation of gene expression rather than catalysis or ligand binding.

Other names
LINC01425
02

Biological functions

Gene expression regulationChromatin remodelingRNA stabilizationTranscriptional regulationEnhancer-associated activityOther
03

Disease associations

Cancer (reported in lncRNA panels for differential diagnosis and biomarker discovery in lung cancer and potentially other tumor types[2])Other
04

Biomarkers

Prognostic biomarker (cancer, specifically referenced for biomarker screening in lung cancer[2])

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1425 (LINC01425).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1425 (LINC01425).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call